Clinical Trial Update: Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients [NA]

View source ↗

Summary

Clinical trial update on using chemotherapy in combination with local radiotherapy and rhGM-CSF for oligometastatic stage IV non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• RhGM-CSF (sargramostim (recombinant human granulocyte-macrophage colony-stimulating factor))

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Carcinoma, Non-Small-Cell Lung | NA | Status: UNKNOWN